Ultracet

Indications for Use

Ultracet is prescribed for the short-term treatment of acute pain. It is typically used in situations where pain is moderate to moderately severe and requires the strength of an opioid medication combined with a non-opioid pain reliever.

Common Uses

• Short-term management of pain resulting from injuries or medical procedures.
• Treatment of acute pain that has not been adequately controlled by other non-opioid pain medications.
• Management of pain for a limited duration, usually five days or less.

This medication is intended for use only when other pain management options, such as non-opioid medications, are not tolerated or do not provide enough relief. Because it contains an opioid, it is used for the shortest period necessary to manage the patient's pain.

Mechanism of Action

Ultracet is a combination medication containing tramadol and acetaminophen. These two components work through different mechanisms in the body to provide pain relief.

Tramadol

Tramadol belongs to a class of medications known as opioid analgesics. It works in the brain and spinal cord to change how the nervous system senses and reacts to pain. It achieves this by:

• Binding to specific opioid receptors in the central nervous system.
• Influencing the activity of chemical messengers, such as serotonin and norepinephrine, which are involved in the transmission of pain signals.

Acetaminophen

Acetaminophen is a non-opioid pain reliever and fever reducer. While its exact mechanism of action is not fully understood, researchers believe it works primarily in the central nervous system to increase the body's overall pain threshold. By raising this threshold, it makes the body less sensitive to pain.

By combining these two ingredients, the medication addresses pain through multiple pathways, which may provide more effective relief for short-term pain management than using either ingredient alone.

Common Side Effects

Ultracet may cause side effects that are often mild. These can include:

• Dizziness or drowsiness
• Nausea and vomiting
• Constipation
• Stomach pain
• Headache
• Dry mouth
• Sweating
• Nervousness or anxiety
• Itching

Serious Side Effects

Some side effects require immediate medical care. Contact a healthcare provider right away if you experience:

• Slowed or shallow breathing
• Seizures
• Signs of an allergic reaction, such as hives, skin rash, or swelling of the face, lips, tongue, or throat
• Severe skin reactions, including redness, blistering, or peeling
• Serotonin syndrome symptoms, such as agitation, hallucinations, fever, shivering, fast heart rate, muscle twitching, or loss of coordination
• Signs of liver damage, including yellowing of the skin or eyes, dark urine, or extreme tiredness
• Fainting or severe lightheadedness
• Chest pain
• Changes in heartbeat

Boxed Warnings

Ultracet carries several boxed warnings due to the potential for serious harm:

• Addiction and Misuse: Use of this medication exposes individuals to the risks of opioid addiction, abuse, and misuse, which can lead to overdose and death.
• Respiratory Depression: Serious, life-threatening, or fatal breathing problems may occur. Monitoring is especially important during the start of treatment or after a dose increase.
• Accidental Ingestion: Accidental ingestion of even one dose, especially by children, can result in a fatal overdose.
• Neonatal Opioid Withdrawal Syndrome: Prolonged use during pregnancy can result in life-threatening withdrawal symptoms in the newborn.
• Hepatotoxicity: Acetaminophen has been associated with cases of acute liver failure, sometimes resulting in liver transplant or death. Most cases are linked to doses exceeding 4,000 milligrams per day or using more than one product containing acetaminophen.

Contraindications

Ultracet should not be used in certain populations or conditions, including:

• Children younger than 12 years of age.
• Children younger than 18 years of age following surgery to remove tonsils or adenoids.
• Individuals with significant breathing problems, such as acute or severe bronchial asthma in an unmonitored setting.
• Individuals with a known or suspected blockage in the stomach or intestines, such as paralytic ileus.
• Those who have taken a monoamine oxidase inhibitor (MAOI) within the last 14 days.
• Individuals with a known hypersensitivity to tramadol, acetaminophen, or any other component of the drug.

Other Serious Risks

Seizures: Tramadol can increase the risk of seizures, even at recommended doses. This risk is higher in people with a history of seizure disorders or those taking certain other medications, such as antidepressants or other opioids.

Serotonin Syndrome: A potentially life-threatening condition called serotonin syndrome may occur, particularly when Ultracet is used with other drugs that affect serotonin levels. Symptoms may include agitation, hallucinations, rapid heartbeat, or muscle rigidity.

Adrenal Insufficiency: Cases of adrenal insufficiency have been reported with opioid use, often after more than one month of use. This condition occurs when the adrenal glands do not produce enough cortisol.

Severe Skin Reactions: Acetaminophen may cause rare but serious skin reactions, such as Stevens-Johnson syndrome or toxic epidermal necrolysis, which require immediate medical attention.

Hypotension: Ultracet may cause severe low blood pressure, including dizziness or fainting when standing up suddenly.

Pregnancy

Using Ultracet during pregnancy, especially for a long period, may cause the baby to experience life-threatening withdrawal symptoms after birth, a condition known as neonatal opioid withdrawal syndrome. Symptoms in the newborn may include irritability, hyperactivity, unusual sleep patterns, high-pitched crying, tremors, vomiting, diarrhea, and failure to gain weight.

Ultracet is also not recommended for use immediately before or during labor. The medication can cause breathing problems (respiratory depression) in the newborn baby.

Breastfeeding

Healthcare providers generally advise against breastfeeding while taking Ultracet. Tramadol and its active metabolite pass into breast milk and can cause serious side effects in a nursing infant, including:

• Extreme sleepiness
• Difficulty breastfeeding
• Limpness
• Serious breathing problems that may be life-threatening

If you are pregnant, planning to become pregnant, or breastfeeding, it is important to talk with your healthcare provider about the potential risks and benefits of using this medication.

Available Forms

Ultracet is supplied in the following form:

• Oral Tablet: A film-coated tablet containing a combination of two different pain-relieving medications.

These tablets are designed to be swallowed whole and are typically identified by their specific shape and the markings imprinted on the surface of the medication.

FDA Approval and Indications

Ultracet is approved by the U.S. Food and Drug Administration (FDA) for the short-term management of acute pain. Clinical guidelines and FDA labeling specify that its use should be limited to five days or less.

Boxed Warnings

The FDA has issued several boxed warnings for Ultracet, which is the most serious type of warning required for prescription medications. These warnings include:

• Addiction, Abuse, and Misuse: Exposure to tramadol increases the risk of opioid addiction and misuse, which can lead to overdose and death.
• Life-Threatening Respiratory Depression: Fatal breathing problems may occur, particularly when starting the medication or after a dose increase.
• Accidental Ingestion: Ingesting even a single dose accidentally, especially by a child, can result in a fatal overdose.
• Neonatal Opioid Withdrawal Syndrome: Use during pregnancy for an extended period can cause life-threatening withdrawal symptoms in the infant.
• Hepatotoxicity: Acetaminophen has been linked to acute liver failure, which may lead to liver transplant or death.
• Interactions with Benzodiazepines: Combining this drug with benzodiazepines or other central nervous system depressants can cause profound sedation, respiratory failure, and death.

Regulatory Oversight and REMS

Ultracet is part of the FDA-mandated Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS). This program requires healthcare providers to be educated on the risks and safe use of opioid products. Additionally, tramadol is classified as a Schedule IV controlled substance due to its potential for abuse and physical or psychological dependence.

Safety Restrictions in Children

The FDA has issued specific contraindications for tramadol-containing products in pediatric populations. It must not be used in children under 12 years of age. It is also contraindicated for use in children under 18 years of age to treat pain after surgery to remove tonsils or adenoids.

Withdrawal Symptoms

Because Ultracet contains tramadol, the body can develop a physical dependence if the medication is used regularly over time. If you stop taking it suddenly, you may experience withdrawal symptoms. These symptoms often include:

• Nervousness, restlessness, or anxiety
• Insomnia or difficulty sleeping
• Sweating, chills, or shivering
• Nausea, diarrhea, or stomach pain
• Body aches and tremors
• Upper respiratory symptoms like a runny nose or sneezing
• Piloerection (goosebumps)

Less commonly, some individuals may experience severe anxiety, panic attacks, or hallucinations when the medication is stopped abruptly.

How to Stop Safely

You should not stop taking Ultracet without consulting your doctor. To minimize withdrawal effects, your healthcare provider will usually create a plan to gradually taper your dose. This allows your body to adjust slowly to the decreasing levels of medication. If you notice any severe or concerning symptoms while reducing your dose, seek medical advice immediately.